In vascular endothelial growth factor (VEGF) signaling inhibition–related glomerular diseases, such as thrombotic microangiopathy associated with anti-VEGF therapy or pre-eclampsia35,36, glomerular hyaluronan is diminished in association with proteinuria15,37,38. This evidence concerns the gene VEGFA and Genetic thrombotic microangiopathy.